Relative Response Factor (RRF) and its Calculation in HPLC Analysis

Relative Response Factor (RRF) and its Calculation in HPLC Analysis

Know about the relative response factor and its calculation in system suitability parameters in HPLC analysis of pharmaceutical substances and pharmaceutical products.

During the manufacturing process of active pharmaceutical ingredients, some unwanted substances are produced those are known as impurities. Some impurities are raised due to the degradation of the actual drug.

Impurities in pharmaceutical drug substances and drug products are required to be analyzed for the quantity of the impurities. To determine the actual quantity of the impurity it is required to have impurity standard. In the absence of the impurity standard relative response factor (RRF) may be used to calculate the actual quantity of the impurity.

Q3B R2 of ICH Guidelines also says that if the response factor is determined correctly, it can be used to measure the actual amount of impurity. Identification threshold, quantification threshold and reporting threshold are given by ICH and it is important to determine the impurities within these thresholds.

Relative Response Factor (full form of RRF) is an alternate method for the determination of the quantity of the impurities present in pharmaceutical products and amount of the impurity can be calculated with the help of peak area of the components.

Relative response factor is the ratio of the response of the impurity and the active pharmaceutical ingredient (API) under the identical chromatographic conditions (chromatographic column, temperature, mobile phase, flow rate etc).

Relative response factor is determined by analyzing the impurity standard and API standard of equal concentration. The following formula is used to determine the response factor:

Response Factor (RF) = Peak Area
Concentration in mg/ml

Relative Response Factor (RRF) = Response Factor of impurity
Response Factor of API

RF in chromatography for different products are different and should be determined for individual substance. Relative response factor determined on a particular detector cannot be used in the calculation of product determined on another detector because different detectors show the difference in the response of the same compound.

Solutions of at least three different concentrations of standard and impurity are prepared and injected in HPLC. The slop of area and concentration of impurity and standard are calculated to determine the relative response factor.
Also see: Theoretical Plates and their Determination in HPLC Analysis

Comments

Sterility Testing by Direct Inoculation Method

Sterility Testing by Direct Inoculation Method Direct Inoculation Method Learn the procedure for sterility test for sterile pharmaceutical products by direct inoculation method. 1.0 Objective : To lay down Standard Operating Procedure is to provide guidelines for sterility testing by Direct Inoculation Method. 2.0 Scope This procedure is applicable for the products manufactured at the location which can not be tested by Membrane Filtration Method. 3.0 Responsibility Implementation: Microbiologist 4.0 Accountability Execution: Manager - QC Review & Approval : AGM - QA / QC Procedure Direct Inoculation Method Sample for Finished Products: Collect the samples to be tested for sterility. Out of the whole sample, randomly select 20 articles of each lot of batch for both LVP and SVP t erminal ly sterilized products and for aseptically filled products. Sample for Intermediates: Randomly collect 16 pre-sterilized bottle samples to be tested for sterility from LVP bot...

SOP for Washing of HPLC Column After Use

SOP for Washing of HPLC Column After Use Standard operating procedure to wash the HPLC column after analysis. 1.0 OBJECTIVE To clean the column thoroughly after its each use to avoid any interference on repeated usage. 2.0 SCOPE This procedure is applicable for different groups of H.P.L.C columns used in Quality Control laboratory. 3.0 RESPONSIBILITY 2.1 Doing: Technical Assistant 2.2 Checking: Executive /Manager 4.0 ACCOUNTABILITY Head of the Department 5.0 PROCEDURE 5.1 For C18, C8, C6, Phenyl, (CN, Amine, Silica column.:) 5.1.1 Wash the column with the solvent which is use in individual product mobile phase preparation. eg. suppose water is use in mobile phase preparation then wash the column with water. 5.1.2 Allow the minimum 30 ml washing medium to flow through the column. 5.1.3 Disconnect the column from the HPLC unit and store in an allocated place. 5.2 For Protein pack column: 5.2.1 Wash the column with minimum 30 ml of 2.5 M acetic acid. 5.2.4 Disconnect the column from ...

Blow Fill Seal (BFS) and Form Fill Seal (FFS) Technology in Sterile Manufacturing

Blow Fill Seal (BFS) and Form Fill Seal (FFS) Technology in Sterile Manufacturing Know about sterile pharmaceutical production using Blow Fill Seal (BFS) and Form Fill Seal (FFS) technology. Both of these techniques are used to manufacture sterile pharmaceutical products as parenteral (LVP & SVP), infusions, ophthalmic and inhalation products. These are automated techniques to prepare sterile products. The basic concept of the FFS and BFS is to reduce the contamination by forming the container, filling and sealing in a closed sterile chamber of the machine. There is no personnel intervention to reduce the chances of the contamination during the manufacturing of sterile products. It gives more production at very low operational cost with the high assurance of sterility . Blow fill seal technology is widely used and accepted by the various pharmaceutical regulatory authorities as US-FDA and MHRA. The system is being used for over 30 years a...

High-Efficiency Particulate Air (HEPA) and Its Significance in Sterile Pharmaceutical Preparations

High-Efficiency Particulate Air (HEPA) and Its Significance in Sterile Pharmaceutical Preparations Everything about HEPA filters as pore size, leak test, DOP test and importance in sterile pharmaceutical manufacturing and analysis. HEPA filter integrity should be maintained to ensure aseptic conditions. Leak testing should be performed at installation to detect integrity breaches around the sealing gaskets, through the frames, or through various points on the filter media. Thereafter, leak tests should be performed at suitable time intervals for HEPA filters in the aseptic processing facility. For example, such testing should be performed twice a year in the aseptic processing room. Additional testing may be appropriate when air quality is found to be unacceptable, facility renovations might be the cause of disturbances to ceiling or wall structures, or as part of an investigation into a media fill or drug product sterility failure. Among the filters that should be leak tested ar...

Media Fill Test for Sterile API Manufacturing Process

Media Fill Test for Sterile API Manufacturing Process Know about the process simulation test for the active pharmaceutical ingredient (API) manufacturing process. Media fill test is done to verify the sterility of the sterile manufacturing process. Media fill validation for sterile API is different from the sterile formulation media fill. There are different processes in the sterile API manufacturing as filtration, crystallization, drying, milling etc. These all are different from the sterile formulation process where the sterile material is filled in sterile containers in aseptic conditions . Lactose powder is used in the process simulation. The whole media fill process is carried out in two phases 1) Wet Phase 2) Dry phase 1) Wet Phase: Non-sterile lactose powder is used in the wet phase. Wet phase simulates the liquid processing steps of the manufacturing process i.e. aseptic filtration of lactose solution from controlled area reactor to cryst...

Pharmaceutical Guidelines

Search This Blog